Medication info
Simvastatin 20 mg Tablets (Simvastatin)

Simvastatin 20 mg Tablets (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
KMS Pharmaceutical Co., Ltd.
Appearance
Brown-yellow oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200403258 · Notified 2004.05.11 · Insurance code 654700360

Summary

Main use
Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; reduction of cardiovascular disease risk
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The recommended initial dose is 40 mg of simvastatin once daily. The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the baseline LDL cholesterol level before treatment, the treatment target, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatment (e.g., LDL apheresis), or when other lipid-lowering treatment is not available. In older adults, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. This medicine is effective when used alone or in combination with bile acid sequestrants. When this medicine is coadministered with fibrates (excluding gemfibrozil (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. Since this medicine is not extensively excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, initiate treatment at 5 mg per day and monitor carefully.
Child dose
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dosage range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goals. Dose adjustments should be made at intervals of 4 weeks or longer.

Ingredients

Manufacturer
KMS Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; reduction of cardiovascular disease risk

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hyperlipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • dysbetalipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication is used to lower the risk of cardiovascular diseases. In particular, it reduces the risk of cardiac events in adult patients with a history of coronary heart disease, stroke, or peripheral vascular disease. It also helps to improve cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. In pediatric patients with heterozygous familial hypercholesterolemia, it is used as an adjunct to diet to lower cholesterol levels. This medication plays an important role in protecting and improving heart and vascular health.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The recommended initial dose is 40 mg of simvastatin once daily. The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the baseline LDL cholesterol level before treatment, the treatment target, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatment (e.g., LDL apheresis), or when other lipid-lowering treatment is not available. In older adults, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. This medicine is effective when used alone or in combination with bile acid sequestrants. When this medicine is coadministered with fibrates (excluding gemfibrozil (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. Since this medicine is not extensively excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, initiate treatment at 5 mg per day and monitor carefully.

Child dose

10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dosage range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goals. Dose adjustments should be made at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle-related side effects such as myopathy or rhabdomyolysis, especially at high doses. Therefore, if muscle pain or weakness occurs while taking a high dose, you should immediately consult your physician. Patients with a known allergy to this medication or those with liver disease, pregnant or nursing women, or those taking certain medications should not use this medication. Patients with liver or kidney issues, alcohol dependence, or a history of hypothyroidism should use this medication with caution. Regular liver function and muscle-related tests are recommended during therapy, and any unusual symptoms should be reported to healthcare professionals immediately. This medication can interact with many other drugs, so if you are taking other medications, you must inform your physician or pharmacist. Special caution is needed when being taken with CYP3A4 inhibitors, certain antibiotics, calcium channel blockers, and fibrate drugs. Pregnant women should avoid this medication, and women who may become pregnant should ensure effective contraception while taking it. Nursing mothers are also advised to stop breastfeeding while on this medication. Elderly patients and pediatric patients should also use caution, particularly in elderly patients, where the risk of muscle-related side effects may be higher. In case of overdose, you should immediately visit a medical facility for appropriate treatment. This medication should be stored away from direct sunlight and kept out of reach of children, preferably in its original container.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 86 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • cholecystitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • oculomotor dysfunction
  • facial paresis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • depression
  • cognitive impairment
  • severe muscle weakness
  • ocular muscle weakness
  • hepatitis
  • jaundice
  • pancreatitis
  • liver failure
  • cholemic jaundice
  • fatty liver changes
  • cirrhosis
  • fulminant liver necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • increased bilirubin level
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • sensory dullness in limbs
  • numbness
  • cold sensation
  • thrombocytopenia
  • lupus-like erythema
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • erythema multiforme
  • interstitial lung disease
  • vomiting
  • mucus stools

Not everyone experiences these, and they can vary from person to person.

Storage

Keep this medication in a tightly sealed container to prevent exposure to air and store at room temperature between 1°C and 30°C. Proper storage helps maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Brown-yellow oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.